Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C-Reference-Cited by-同舟云学术

Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C

Published:2017-10-29 Issue:1 Volume:11 Page:69-74
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Kawaguchi Toshihiro^ORCID,Ide Tatsuya,Koga Hironori,Kondo Reiichiro,Miyajima Ichiro,Arinaga-Hino Teruko,Kuwahara Reiichiro,Amano Keisuke,Niizeki Takashi,Nakano Masahito,Kuromatsu Ryoko,Torimura Takuji

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1007/s12328-017-0789-1/fulltext.html

Reference25 articles.

1. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med. 1986;315:1575–8.

2. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–82.

3. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology. 2003;124:1711–9.

4. Pawlotsky JM. New hepatitis C therapy: the toolbox, strategies, and challenges. Gastroenterology. 2014;146:1176–92.

5. Majumdar A, Kitson MT, Roberts SK, et al. Systematic review; current concepts and challenges for the direct-acting era in hepatitis C cirrhosis. Aliment Pharmacol Ther. 2016;43:1276–92.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan;Digestive Diseases and Sciences;2024-07-04

2. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan;2024-04-10

3. Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C;Digestive Diseases and Sciences;2022-09-14

4. A case of hepatitis C-related cirrhosis that developed cancer of unknown primary origin and followed with fulminant course after treatment with direct-acting antivirals;Kanzo;2022-02-01

5. Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers;The British Journal of Radiology;2021-11-01